^
    6ms
    NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management (GlobeNewswire)
    "NeoGenomics, Inc...will showcase its versatile lung solution and its COMPASS Hematopathology Services portfolio at the American Society of Clinical Oncology (ASCO) conference in Chicago, May 31–June 4 (booth #31093)....NeoGenomics will also feature COMPASS, a suite of single-order sample-to-diagnosis services for hematological malignancies."
    Clinical
    |
    InVisionFirst®-Lung • Neo Comprehensive™ - Heme Cancers
    1year
    NeoGenomics announces the commercial availability of two new tests, expanding its next-generation sequencing and lung cancer portfolios (NeoGenomics Press Release)
    "NeoGenomics, Inc...announced the commercial availability of two new tests, expanding its cancer portfolio of innovative products. These include Neo Comprehensive - Heme Cancers, a next-generation sequencing (NGS) panel with a comprehensive genomic profile of hematologic malignancies, and Early-stage Non-Small Cell Lung Cancer (NSCLC) Panel, a therapy selection panel designed specifically for early-stage NSCLC patients."
    Commercial
    |
    Early-stage NSCLC Panel • Neo Comprehensive™ - Heme Cancers